(Q45732357)

15 December 2017

title

Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin (English)

1 reference

15 December 2017

4

Eric A F Simoes

1 reference

15 December 2017

Sally E Wenzel

1

1 reference

15 December 2017

Robyn L Gibbs

series ordinal

2

1 reference

15 December 2017

Marsha V Lehr

series ordinal

3

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

American Journal of Medicine

15 December 2017

published in

1 reference

15 December 2017

volume

112

1 reference

15 December 2017

issue

8

1 reference

15 December 2017

page(s)

627-633

1 reference

Respiratory status and allergy nine to 10 years after acute bronchiolitis

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Association of radiologically ascertained pneumonia before age 3 yr with asthmalike symptoms and pulmonary function during childhood: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Childhood sequelae of infant lung disease: exercise and pulmonary function abnormalities after bronchopulmonary dysplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Lung function outcome in children of premature birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Respiratory symptoms at age 8 years in a cohort of very low birth weight children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Effect of respiratory syncytial virus infection on the uptake of and immune response to other inhaled antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Respiratory syncytial virus and wheeze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Anaphylactic sensitization to aeroantigen during respiratory virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab')2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901095-1

10.1016/S0002-9343(02)01095-1

7 January 2021

Identifiers

DOI

1 reference

release_nqrp3lweqbcctcyywjg2wopjxy

15 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nqrp3lweqbcctcyywjg2wopjxy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference